HomeKNE • CVE
add
Kane Biotech Inc
Previous close
$0.13
Day range
$0.13 - $0.14
Year range
$0.050 - $0.17
Market cap
16.44M CAD
Avg Volume
284.01K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | — | — |
Net income | — | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 749.25K | -32.19% |
Total assets | 5.68M | 1.09% |
Total liabilities | 14.09M | 44.40% |
Total equity | -8.41M | — |
Shares outstanding | 131.84M | — |
Price to book | -1.62 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | — | — |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2001
Headquarters
Website